Hagop Kantarjian, who chairs the leukemia department at the MD Anderson Cancer Center in Houston and who spearheaded the commentary piece, acknowledged that his effort may hurt his research career with the pharmaceutical industry.
This pattern of rationalization and decreased responsibility is "very common, " says Patrick Lyden, MD, the chair of the department of neurology at Cedars-Sinai Medical Center, in Los Angeles.